Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer Science|November 28, 2017
PRDM14 directly interacts with heat shock proteins HSP90α and glucose-regulated protein 78Chiharu Moriya, Hiroaki Taniguchi, Satoru Nagatoishi, et al.
Cancer Science|August 31, 2016
Cancer stem cells in human gastrointestinal cancerHiroaki Taniguchi, Chiharu Moriya, Hisayoshi Igarashi, et al.
Clinical Journal of Gastroenterology|September 21, 2018
Chronic intestinal pseudo-obstruction due to al amyloidosis: a case report and literature reviewTomoya Iida, Daisuke Hirayama, Gota Sudo, et al.
Digestion|January 25, 2014
HER2 expression and PI3K-Akt pathway alterations in gastric cancerYasutaka Sukawa, Hiroyuki Yamamoto, Katsuhiko Nosho, et al.
Carcinogenesis|June 4, 2018
MicroRNA-31 reflects IL-6 expression in cancer tissue and is related with poor prognosis in bile duct cancerKeisuke Ishigami, Katsuhiko Nosho, Hideyuki Koide, et al.
World Journal of Gastroenterology|September 19, 2014
MicroRNA-31 expression in colorectal serrated pathway progressionHironori Aoki, Katsuhiko Nosho, Hisayoshi Igarashi, et al.
World Journal of Gastroenterology|January 27, 2016
Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancerKatsuhiko Nosho, Yasutaka Sukawa, Yasushi Adachi, et al.
Oncotarget|June 20, 2015
Analysis of the molecular features of rectal carcinoid tumors to identify new biomarkers that predict biological malignancyKei Mitsuhashi, Itaru Yamamoto, Hiroyoshi Kurihara, et al.
Oncotarget|February 13, 2016
The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathwayHiroyoshi Kurihara, Reo Maruyama, Kazuya Ishiguro, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 28, 2011
Irinotecan as the key chemotherapeutic agent in second-line treatment of metastatic gastric cancer after failure of first-line S-1 or S-1/CDDP therapyAkira Goto, Yasutaka Sukawa, Hisayoshi Igarashi, et al.
Pageof 2